BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 34046997)

  • 1. Inter-fractional error and intra-fractional motion of prostate and dosimetry comparisons of patient position registrations with versus without fiducial markers during treatment with carbon-ion radiotherapy.
    Iwai Y; Mori S; Ishikawa H; Kanematsu N; Matsumoto S; Nakaji T; Okonogi N; Kobayashi K; Wakatsuki M; Uno T; Yamada S
    Radiol Phys Technol; 2024 Jun; 17(2):504-517. PubMed ID: 38691309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of rectal sparing throughout the course of proton therapy treatment in prostate cancer patients treated with SpaceOAR
    Hedrick SG; Fagundes M; Case S; Renegar J; Blakey M; Artz M; Chen H; Robison B; Schreuder N
    J Appl Clin Med Phys; 2017 Jan; 18(1):82-89. PubMed ID: 28291933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetric comparison between stereotactic body radiotherapy and carbon-ion radiation therapy for prostate cancer.
    Huang HF; Gao XX; Li Q; Ma XY; Du LN; Sun PF; Li S
    Quant Imaging Med Surg; 2023 Oct; 13(10):6965-6978. PubMed ID: 37869307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric Features of Ultra-Hypofractionated Intensity Modulated Proton Therapy for Prostate Cancer.
    Gao RW; Ma J; Pisansky TM; Kruse JJ; Stish BJ; Kowalchuk RO; McMenomy BP; Waddle MR; Phillips RM; Choo R; Davis BJ
    Int J Part Ther; 2024 Jun; 12():100015. PubMed ID: 38827121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose distribution estimation toward CT-less adaptive carbon ion radiotherapy for liver tumors using the divided-volume matching technique.
    Chen JN; Ohno T; Tashiro M
    Phys Med Biol; 2023 Oct; 68(20):. PubMed ID: 37738990
    [No Abstract]   [Full Text] [Related]  

  • 6. Creation, evolution, and future challenges of ion beam therapy from a medical physicist's viewpoint (Part 2). Chapter 2. Biophysical model, treatment planning system and image guided radiotherapy.
    Endo M
    Radiol Phys Technol; 2023 Jun; 16(2):137-159. PubMed ID: 37129777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term experience in quality assurance of on-rail computed tomography systems for image-guided radiotherapy using in-house multifunctional phantoms.
    Saito M; Sano N; Suzuki H; Komiyama T; Marino K; Ueda K; Nemoto H; Onishi H
    Radiol Phys Technol; 2023 Jun; 16(2):292-298. PubMed ID: 37079253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Safety for Scanning Carbon-Ion Radiotherapy in Hemodialysis Patients With Prostate Cancer.
    Takakusagi Y; Suga M; Kusano Y; Kano K; Shima S; Tsuchida K; Mizoguchi N; Serizawa I; Yoshida D; Kamada T; Minohara S; Katoh H
    Cureus; 2022 Feb; 14(2):e22214. PubMed ID: 35308759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of image-guided patient repositioning and online planning in localized prostate cancer IMRT.
    Lerma FA; Liu B; Wang Z; Yi B; Amin P; Liu S; Feng Y; Yu CX
    Radiother Oncol; 2009 Oct; 93(1):18-24. PubMed ID: 19592122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evidence of particle beam therapy (carbon).
    Kamada T
    Int J Clin Oncol; 2012 Apr; 17(2):85-8. PubMed ID: 22426888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interfractional robustness of scanning carbon ion radiotherapy for prostate cancer: An analysis based on dose distribution from daily in-room CT images.
    Tsuchida K; Minohara S; Kusano Y; Kano K; Anno W; Takakusagi Y; Mizoguchi N; Serizawa I; Yoshida D; Imura K; Takayama Y; Kamada T; Katoh H; Ohno T
    J Appl Clin Med Phys; 2021 Jun; 22(6):130-138. PubMed ID: 34046997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probabilistic dose distribution from interfractional motion in carbon ion radiation therapy for prostate cancer shows rectum sparing with moderate target coverage degradation.
    Bridges D; Kawamura H; Kanai T
    PLoS One; 2018; 13(8):e0203289. PubMed ID: 30169520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing 3DCT image registration for interfractional changes in carbon-ion prostate radiotherapy.
    Hirai R; Mori S; Suyari H; Tsuji H; Ishikawa H
    Sci Rep; 2023 May; 13(1):7448. PubMed ID: 37156901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positioning accuracy and daily dose assessment for prostate cancer treatment using in-room CT image guidance at a proton therapy facility.
    Maeda Y; Sato Y; Minami H; Yasukawa Y; Yamamoto K; Tamamura H; Shibata S; Bou S; Sasaki M; Tameshige Y; Kume K; Ooto H; Kasahara S; Shimizu Y; Saga Y; Omoya A; Saitou M
    Med Phys; 2018 May; 45(5):1832-1843. PubMed ID: 29532489
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.